Economic potential of probiotic supplementation in institutionalized elderly with chronic constipation

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Probiotics have been suggested as an effective supplementation to conventional treatment regimens for chronic constipation in nursing homes, but the financial impact of the intervention for these institutions remains to be determined. We therefore set out to investigate the economic potential of probiotic supplementation in a nursing home setting with regard to constipation management. We aimed to determine the probiotic lower efficacy limit required to reduce the institution's constipation-related expenses, based on quantitative data obtained from nursing home employees. A meta-analysis was conducted on clinical studies reporting the effects of probiotic intervention on constipation status in institutionalized elderly, in order to estimate the probiotic treatment effect. Our results indicate that the constipation-related expenses of an average-sized nursing home with 100 residents and a constipation prevalence of 42%, amount to approximately €90,000 per year. Daily probiotic supplementation of all nursing home residents may reduce the institution's expenses by €8,000-€25,000 annually, as probiotic intervention is suggested to lower the constipation prevalence by 28%. To further substantiate the proposed economic potential of probiotic supplementation, however, it is recommended that the probiotic treatment effect on the workload for nursing home employees is addressed in appropriately scaled and controlled future clinical trials.

LanguageEnglish
Pages198-206
Number of pages9
JournalPharmaNutrition
Volume6
Issue number4
Early online date9 Oct 2018
DOIs
Publication statusPublished - Dec 2018

Fingerprint

constipation
Probiotics
Constipation
probiotics
nursing homes
Economics
Nursing Homes
economics
human resources
clinical trials
Controlled Clinical Trials
economic impact
Workload
meta-analysis
Meta-Analysis
Therapeutics

Keywords

  • Constipation
  • Elderly
  • Health economics
  • Meta-analysis
  • Nursing homes
  • Probiotics

Cite this

@article{5390b7961b6d4634b9428f74c4b375e0,
title = "Economic potential of probiotic supplementation in institutionalized elderly with chronic constipation",
abstract = "Probiotics have been suggested as an effective supplementation to conventional treatment regimens for chronic constipation in nursing homes, but the financial impact of the intervention for these institutions remains to be determined. We therefore set out to investigate the economic potential of probiotic supplementation in a nursing home setting with regard to constipation management. We aimed to determine the probiotic lower efficacy limit required to reduce the institution's constipation-related expenses, based on quantitative data obtained from nursing home employees. A meta-analysis was conducted on clinical studies reporting the effects of probiotic intervention on constipation status in institutionalized elderly, in order to estimate the probiotic treatment effect. Our results indicate that the constipation-related expenses of an average-sized nursing home with 100 residents and a constipation prevalence of 42{\%}, amount to approximately €90,000 per year. Daily probiotic supplementation of all nursing home residents may reduce the institution's expenses by €8,000-€25,000 annually, as probiotic intervention is suggested to lower the constipation prevalence by 28{\%}. To further substantiate the proposed economic potential of probiotic supplementation, however, it is recommended that the probiotic treatment effect on the workload for nursing home employees is addressed in appropriately scaled and controlled future clinical trials.",
keywords = "Constipation, Elderly, Health economics, Meta-analysis, Nursing homes, Probiotics",
author = "J. Flach and M. Koks and {van der Waal}, {M. B.} and E. Claassen and Larsen, {O. F.A.}",
year = "2018",
month = "12",
doi = "10.1016/j.phanu.2018.10.001",
language = "English",
volume = "6",
pages = "198--206",
journal = "PharmaNutrition",
issn = "2213-4344",
publisher = "Elsevier BV",
number = "4",

}

Economic potential of probiotic supplementation in institutionalized elderly with chronic constipation. / Flach, J.; Koks, M.; van der Waal, M. B.; Claassen, E.; Larsen, O. F.A.

In: PharmaNutrition, Vol. 6, No. 4, 12.2018, p. 198-206.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - Economic potential of probiotic supplementation in institutionalized elderly with chronic constipation

AU - Flach, J.

AU - Koks, M.

AU - van der Waal, M. B.

AU - Claassen, E.

AU - Larsen, O. F.A.

PY - 2018/12

Y1 - 2018/12

N2 - Probiotics have been suggested as an effective supplementation to conventional treatment regimens for chronic constipation in nursing homes, but the financial impact of the intervention for these institutions remains to be determined. We therefore set out to investigate the economic potential of probiotic supplementation in a nursing home setting with regard to constipation management. We aimed to determine the probiotic lower efficacy limit required to reduce the institution's constipation-related expenses, based on quantitative data obtained from nursing home employees. A meta-analysis was conducted on clinical studies reporting the effects of probiotic intervention on constipation status in institutionalized elderly, in order to estimate the probiotic treatment effect. Our results indicate that the constipation-related expenses of an average-sized nursing home with 100 residents and a constipation prevalence of 42%, amount to approximately €90,000 per year. Daily probiotic supplementation of all nursing home residents may reduce the institution's expenses by €8,000-€25,000 annually, as probiotic intervention is suggested to lower the constipation prevalence by 28%. To further substantiate the proposed economic potential of probiotic supplementation, however, it is recommended that the probiotic treatment effect on the workload for nursing home employees is addressed in appropriately scaled and controlled future clinical trials.

AB - Probiotics have been suggested as an effective supplementation to conventional treatment regimens for chronic constipation in nursing homes, but the financial impact of the intervention for these institutions remains to be determined. We therefore set out to investigate the economic potential of probiotic supplementation in a nursing home setting with regard to constipation management. We aimed to determine the probiotic lower efficacy limit required to reduce the institution's constipation-related expenses, based on quantitative data obtained from nursing home employees. A meta-analysis was conducted on clinical studies reporting the effects of probiotic intervention on constipation status in institutionalized elderly, in order to estimate the probiotic treatment effect. Our results indicate that the constipation-related expenses of an average-sized nursing home with 100 residents and a constipation prevalence of 42%, amount to approximately €90,000 per year. Daily probiotic supplementation of all nursing home residents may reduce the institution's expenses by €8,000-€25,000 annually, as probiotic intervention is suggested to lower the constipation prevalence by 28%. To further substantiate the proposed economic potential of probiotic supplementation, however, it is recommended that the probiotic treatment effect on the workload for nursing home employees is addressed in appropriately scaled and controlled future clinical trials.

KW - Constipation

KW - Elderly

KW - Health economics

KW - Meta-analysis

KW - Nursing homes

KW - Probiotics

UR - http://www.scopus.com/inward/record.url?scp=85055059920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055059920&partnerID=8YFLogxK

U2 - 10.1016/j.phanu.2018.10.001

DO - 10.1016/j.phanu.2018.10.001

M3 - Article

VL - 6

SP - 198

EP - 206

JO - PharmaNutrition

T2 - PharmaNutrition

JF - PharmaNutrition

SN - 2213-4344

IS - 4

ER -